Allianz Asset Management’s Applovin APP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.9M Buy
54,166
+20,647
+62% +$9.96M 0.02% 606
2026
Q1
$13.3M Sell
33,519
-1,044
-3% -$505K 0.01% 760
2025
Q4
$23.3M Sell
34,563
-147,756
-81% -$93.1M 0.02% 538
2025
Q3
$131M Buy
182,319
+10,176
+6% +$4.69M 0.15% 133
2025
Q2
$60.3M Sell
172,143
-35,891
-17% -$11.6M 0.07% 267
2025
Q1
$55.1M Buy
208,034
+181,105
+673% +$62.4M 0.07% 272
2024
Q4
$8.72M Sell
26,929
-31,093
-54% -$7.87M 0.01% 794
2024
Q3
$7.57M Sell
58,022
-1,363
-2% -$124K 0.01% 851
2024
Q2
$4.94M Buy
59,385
+11,296
+23% +$876K 0.01% 970
2024
Q1
$3.33M Buy
+48,089
New +$2.55M 0.01% 1010
2022
Q4
Sell
-13,385
Closed -$261K 1977
2022
Q3
$261K Buy
13,385
+2,436
+22% +$72.8K ﹤0.01% 1612
2022
Q2
$377K Sell
10,949
-61,651
-85% -$2.48M ﹤0.01% 1958
2022
Q1
$4M Buy
+72,600
New +$4.62M ﹤0.01% 1311

Other funds holding APP

Allianz Asset Management's APP Position: Q2 2026 in Review

Allianz Asset Management increased its Applovin (APP) stake by 62% in Q2 2026, buying an estimated $9.96M and bringing the position to 54,166 shares worth $27.9M. The position accounts for 0.02% of the portfolio, ranked #606.

Allianz Asset Management first reported a position in APP in Q1 2022 and has held it in 13 quarters since. The position peaked at $131M in Q3 2025. 1,459 funds tracked by Wall St. Rank hold APP as of Q2 2026.

  • Allianz Asset Management held 54,166 shares of Applovin worth $27.9M as of Q2 2026.
  • Allianz Asset Management bought 20,647 Applovin shares in Q2 2026, an estimated $9.96M.
  • Applovin made up 0.02% of Allianz Asset Management's portfolio in Q2 2026, its #606 holding.
  • Allianz Asset Management first reported a position in Applovin in Q1 2022 and has held it in 13 quarters since.
  • Allianz Asset Management's Applovin position peaked at $131M in Q3 2025.
  • 1,459 funds tracked by Wall St. Rank held Applovin as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.